Clark Financial Services Group Inc Eiger Bio Pharmaceuticals, Inc. Transaction History

Clark Financial Services Group Inc

  • $108 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$5.12 - $8.19 $106,915 - $171,023
-20,882 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$6.68 - $9.1 $1,623 - $2,211
243 Added 1.18%
20,882 $140,000
Q2 2021

Aug 09, 2021
BUY
$7.82 - $9.23 $13,325 - $15,727
1,704 Added 9.0%
20,639 $176,000
Q1 2021

May 17, 2021
BUY
$8.44 - $12.66 $159,811 - $239,717
18,935 New
18,935 $167,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Clark Financial Services Group Inc Portfolio

Follow Clark Financial Services Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Financial Services Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Clark Financial Services Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email